Telegram-
Loading indices

KOSPI · 009290

KwangdongPharm

Market cap₩334B
PER15.73×
PBR0.52×
Foreign ownership15.94%

Pension summary

as of Oct 19
streakNone
5D-₩40M
20D-₩170M
60D-₩240M
Foreign 20D-₩540M
Inst. 20D-₩100M

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/196,710–-₩130M+₩10M+₩120M
10/166,890–+₩120M₩0M-₩120M
10/156,700–+₩640M+₩10M-₩650M
10/146,630-₩20M-₩30M-₩10M+₩40M
10/136,700-₩20M+₩240M-₩10M-₩230M
10/126,810₩0M+₩150M+₩30M-₩180M
10/86,840–-₩210M₩0M+₩240M
10/77,000–-₩130M-₩10M+₩150M
10/66,870–+₩50M+₩10M-₩140M
10/26,580–-₩290M₩0M+₩290M

Discussion

Google-verified members · return since posting
0/300

  1. Loading

세력 매집

last 60 trading days · Oct 19
Foreign 60D−₩1.9B
Pension funds 60D−₩200M
세력 Avg. cost6,352
vs. cost Close+5.6%

Foreign+Pension funds Total 시총의 -0.6%, 60D price 폭 22%·Chg +12.0%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.

세력 매집 구간 All →

Financial score

#336 of KOSPI 500
48.4/100
  • Value15.2
  • Quality6
  • Growth4.5
  • Financials9.5
  • Risk13.2
소외
All stock scores →

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker price targets

Recent 1Y

Recent reports

  1. 스테디셀러 제품군 보유 KRX F&B 및 의약품 제조 기업NICE D&B · 11/01

Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked

Same sector

  1. Samsung Biologics
  2. Celltrion
  3. SAMSUNG EPIS HOLDINGS
  4. Yuhan
  5. SK Biopharm
  6. HanmiPharm

KwangdongPharm summary

KwangdongPharm (009290). Pension funds last 20 trading days -₩170M. Market cap ₩334B, PER 15.73×, PBR 0.52×. Pension flows are based on Korea Exchange investor statistics, for reference only.